A	B	C	D
1	Main
2		Brand	ALN-HSD
3		Indication	NASH
4		MOA	HSD17B3
5		Economics	REGN
6		Clinical Trials
7			Phase I healthy adults/NASH
8			Cohort A healthy adults
9			Cohort B NASH
10				200mg, 400mg q3m
11
12
13			Phase II NASH initiates late 2022